Demonstrating real-world effectiveness in allergy immunotherapy

It's estimated than less than 10% of investigational anti-cancer drugs successfully achieve FDA approval for clinical use. This is often attributed to the fact that it’s difficult to identify patients whose tumors are most likely to respond to a specific treatment. Patient derived xenografts (PDXs) are bringing new hope when it comes to this challenging task, yet finding the ideal animal model to grow the PDX tumors to test new therapies can be challenging. The new B-NDG mouse model is our newest triple immunodeficient mouse with proven performance in cancer and immuno-oncology research.

The global food system is growing rapidly, contributing to the abundance of choices available for consumers and adding complexity to the food supply chain. With numerous connection points and so many participants, there are greater chances for inefficiency, waste, and fraud. Consequently, innovators in the food industry are now recognizing the opportunity to modernize and transform the food system, creating greater trust and transparency throughout. Using Blockchain as the underlying technology for a renewed food system, organizations are realizing unique benefits that accompany the digitization of information. In addition to gaining abilities like instant tracebacks, supply chain efficiency and data insights, participants are acquiring brand differentiation, consumer trust, and sustainability.

Upgrading the CRISPR Toolbox - New Strategies Sharpen the CRISPR-Cas9 Scissors Utilizing Visualization and Chromatic Accessibility

Bio-metrics authentication is fast replacing passwords as the choice of authentication technique on web and mobile applications. This webinar covers various bio-metric options, comparative benefits and emerging trends.